[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)
date : 2/22/2022
Tags: AMR
![[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-case05_ENG-top.jpg)
As part of the Alliance’s project to promote antimicrobial steward among medical professionals, AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun publishing case studies from various experts related to antimicrobial resistance.
Dr. Keisuke Kagami (Department of Pharmacy, Hokkaido University Hospital) and Dr. Mitsuru Sugawara (Department of Pharmacy, Hokkaido University Hospital / Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University) reports a case titled “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.”
In this study, the usefulness of TDM (Therapeutic Drug Monitoring) for antimicrobial stewardship is reported.
Case study 05
Dr. Keisuke Kagami (Department of Pharmacy, Hokkaido University Hospital)
Dr. Mitsuru Sugawara (Department of Pharmacy, Hokkaido University Hospital / Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University)
“Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.”
For further information, please see the case study below.
Case study 01
Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)
“A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment”
Case study 04
Dr. Akari Shigemi (Division of Pharmacy / Department of Infection Control and Prevention, Kagoshima University Hospital)
“The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance”
![[AMR Case Study 04] Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury](/assets/img/katsudo/icon_pdf_l.png){kind=icon}
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
Featured Posts
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)
![[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/cvd-ncd-20241122-top.png)
-
2024-11-01
[Registration Open] Designing for Dementia Briefing Session 2024 – Conversations on the Trajectory of Our Activities and Envisioning the Future (December 3, 2024)
![[Registration Open] Designing for Dementia Briefing Session 2024 – Conversations on the Trajectory of Our Activities and Envisioning the Future (December 3, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20241203-top.png)
-
2024-11-11
[Discussion Points] Women’s Health Project Expert Meeting “The Ideal System for Perinatal Medical Care in Japan in the Era of Declining Birth Rates” (November 11, 2024)
![[Discussion Points] Women’s Health Project Expert Meeting “The Ideal System for Perinatal Medical Care in Japan in the Era of Declining Birth Rates” (November 11, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/wh-20241111-top_ENG.png)
-
2024-11-11
[Registration Open] (Hybrid Format) Obesity Control Promotion Project Public Symposium “Obesity Control as a Social Issue; Toward the Realization of Citizen-Centered Policies” (December 4, 2024)
![[Registration Open] (Hybrid Format) Obesity Control Promotion Project Public Symposium “Obesity Control as a Social Issue; Toward the Realization of Citizen-Centered Policies” (December 4, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20241107_FY2024ObesitySymposium_eyecatch.jpg)
-
2024-11-14
[Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
![[Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20241112_PH_EyeCatch.png)
